FDA Adverse Event Injury Summary report: N

ON-Q PUMP

MDR report key: 2100695 · Received May 18, 2011

Report

Report Number
2026095-2011-00141
Event Type
Injury
Date Received
May 18, 2011
Date of Event
March 31, 2008
Report Date
April 26, 2011
Manufacturer
I-FLOW CORPORATION
Product Code
MEB
PMA / PMN Number
UNK
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CT, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

METHOD: NO PRODUCT WAS RETURNED FOR EVALUATION AND INVESTIGATION. THE LOT NUMBER WAS NOT PROVIDED, THEREFORE, THE DEVICE HISTORY RECORDS COULD NOT BE REVIEWED. RESULTS: THE INFORMATION CONTAINED HEREIN IS BASED ON THE INFORMATION PROVIDED BY THE INITIAL REPORTER. THE REPORT DID NOT PROVIDE ANY SPECIFIC INFORMATION CONCERNING THE PROCEDURE, OR OTHER PARTICULARS OF THE ALLEGED INCIDENT. WITHOUT THE ACTUAL PRODUCT OR DETAILS OF THE INCIDENT, AN ANALYSIS CANNOT BE CONDUCTED. THE ON-Q PUMP DIRECTIONS FOR USE (DFU) CONTAIN A WARNING THAT STATES: "AVOID PLACING THE CATHETER IN JOINT SPACES. ALTHOUGH THERE IS NO DEFINITIVE ESTABLISHED CAUSAL RELATIONSHIP, SOME LITERATURE HAS SHOWN A POSSIBLE ASSOCIATION BETWEEN CONTINUOUS INTRA-ARTICULAR INFUSIONS (PARTICULARLY WITH BUPIVACAINE) AND THE SUBSEQUENT DEVELOPMENT OF CHONDROLYSIS." (DFU 1304265, REV. L). I-FLOW HAS ALSO PREPARED A TECHNICAL BULLETIN ENTITLED "WHAT WE KNOW ABOUT CHONDROLYSIS TODAY". (1303722, REV. E). IF ADDITIONAL INFORMATION THAT IS PERTINENT TO THIS EVENT BECOMES AVAILABLE, I-FLOW WILL SUBMIT A F/U REPORT.

Description of Event or Problem · 1

(DRUG/DILUENT: MARCAINE 0.5%), (FILL VOLUME: 100ML & FLOW RATE: 2ML/HR), (PROCEDURE: ARTHROSCOPIC SURGERY), (CATHPLACE: LEFT KNEE JOINT). PT ALLEGEDLY DEVELOPED CHONDROLYSIS IN HER KNEE FOLLOWING PLACEMENT OF A PAINBUSTER PUMP WHICH CONTINUOUSLY INFUSED LOCAL ANESTHETIC INTO HER KNEE JOINT FOR UP TO 2 DAYS AFTER SURGERY ON OR ABOUT (B)(6) 2008.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ON-Q PUMP ELASTOMERIC PUMP MEB I-FLOW CORPORATION UNK UNK

Patients

Seq Age Sex Outcome Treatment
1 22 YR Other